Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

17.02.2025

2 Am J Surg
5 Ann Surg Oncol
3 BMC Cancer
2 Breast Cancer
1 Breast Cancer (Auckl)
2 Breast Cancer (Dove Med Press)
2 Breast Cancer Res
5 Breast Cancer Res Treat
3 Breast J
2 Cancer Cell
1 Cancer Lett
2 Cancer Res
2 Clin Breast Cancer
1 Eur J Cancer
1 Eur Radiol
1 Gene
1 Genes Chromosomes Cancer
1 J Biol Chem
1 J Natl Cancer Inst
1 J Nucl Med
1 Lancet Oncol
1 Mod Pathol
2 Nature
4 NPJ Breast Cancer
1 PLoS Comput Biol
3 PLoS One
1 Radiol Artif Intell
1 Radiol Imaging Cancer
1 Radiology
1 Radiother Oncol
1 Science



    Am J Surg

  1. FALADE I, Switalla K, Quirarte A, Baxter M, et al
    Balancing risks of surgical complications and positive margins for patients with invasive lobular carcinoma of the breast and elevated BMI: An institutional cohort study.
    Am J Surg. 2025;241:116073.
    >> Share

  2. KHALIL M, Woldesenbet S, Munir MM, Rashid Z, et al
    Surgical opioid prescription and the risk of opioid initiation among opioid-naive households.
    Am J Surg. 2025;241:116029.
    >> Share


    Ann Surg Oncol

  3. HEELING E, Kramer GM, Volders JH, van Bommel ACM, et al
    Increasing Rates but Persistent Variability of Immediate Breast Reconstruction: Real-Time Data from a Population-Based Study (2012-2022).
    Ann Surg Oncol. 2025;32:1997-2006.
    >> Share

  4. OZCAN BB, Arjmandi FK, Polat DS, Xi Y, et al
    Factors Associated with Nodal Positivity Following Neoadjuvant Systemic Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI.
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16985.
    >> Share

  5. BOUGHEY JC, Yu H, Switalla K, Velle L, et al
    Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16973.
    >> Share

  6. REDDY KP, Fayanju OM
    ASO Author Reflections: The Financial Impact of Delayed and Forgone Care Among Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Feb 11. doi: 10.1245/s10434-025-16969.
    >> Share

  7. GAU RY, Chou HH, Tsai HP, Shen SC, et al
    Long-Term Follow-Up of Surgical Outcomes and Oncological Results of Nipple-Sparing Mastectomy with Immediate Reconstruction Through a Single Axillary Incision with Different Approach Methods.
    Ann Surg Oncol. 2025;32:2092-2102.
    >> Share


    BMC Cancer

  8. ZANGOURI V, Balaneji SS, Golmoradi R, Kafili E, et al
    Effects of BMI on prognosis, disease-free survival and overall survival of breast cancer.
    BMC Cancer. 2025;25:257.
    >> Share

  9. FAMILI-YOUTH EHH, Famili-Youth A, Yang D, Siddique A, et al
    Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis.
    BMC Cancer. 2025;25:247.
    >> Share

  10. ZHANG J, Wang Y, Liu Y, Chen H, et al
    Proteomic profiling reveals biological processes and biomarkers involved in the pathogenesis of occult breast cancer.
    BMC Cancer. 2025;25:231.
    >> Share


    Breast Cancer

  11. HARA A, Ozaki A, Murakami M, Saito H, et al
    Breast cancer screening rates and influencing factors among LGBTQ groups in Japan.
    Breast Cancer. 2025 Feb 8. doi: 10.1007/s12282-025-01669.
    >> Share

  12. NAKAYAMA S, Iwamoto T, Araki K, Narui K, et al
    A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy.
    Breast Cancer. 2025 Feb 10. doi: 10.1007/s12282-025-01680.
    >> Share


    Breast Cancer (Auckl)

  13. DE TROY J, Fendt SM, Hatse S, Neven P, et al
    Plasma Iron Levels at Early Breast Cancer Diagnosis Are Associated With Development of Secondary Metastases: A Single-Center Retrospective Cohort Study.
    Breast Cancer (Auckl). 2025;19:11782234251317070.
    >> Share


    Breast Cancer (Dove Med Press)

  14. MA B, Wu G, Zhu H, Liu Y, et al
    The Prediction Model of High-Frequency Ultrasound Combined with Artificial Intelligence-Assisted Scoring System Improved the Diagnosis of Sclerosing Adenosis and Early Breast Cancer.
    Breast Cancer (Dove Med Press). 2025;17:145-155.
    >> Share

  15. KAEWKEDSRI P, Intarawichian P, Jessadapattarakul S, Kunprom W, et al
    Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer.
    Breast Cancer (Dove Med Press). 2025;17:123-143.
    >> Share


    Breast Cancer Res

  16. YANG JS, Cao JM, Sun R, Zhou XJ, et al
    SMYD4 promotes MYH9 ubiquitination through lysine monomethylation modification to inhibit breast cancer progression.
    Breast Cancer Res. 2025;27:20.
    >> Share

  17. ZHANG L, Liu Y, Yang C, Ma J, et al
    Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study.
    Breast Cancer Res. 2025;27:21.
    >> Share


    Breast Cancer Res Treat

  18. TURASHVILI G, Gjeorgjievski SG, Wang Q, Ewaz A, et al
    Intraoperative assessment of axillary sentinel lymph nodes by telepathology.
    Breast Cancer Res Treat. 2023;202:423-434.
    >> Share

  19. CHEN N, Matossian M, Saha P, Rampurwala M, et al
    A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.
    Breast Cancer Res Treat. 2025 Feb 10. doi: 10.1007/s10549-025-07626.
    >> Share

  20. FENG X, Deng Z, McCullough MS, May BJ, et al
    The impact of cardiovascular risk factors on cancer progression: a prospective study in female breast cancer survivors.
    Breast Cancer Res Treat. 2025 Feb 10. doi: 10.1007/s10549-025-07611.
    >> Share

  21. SUBELACK J, Morant R, Blum M, Eichenberger A, et al
    Risk factors for interval breast cancer: insights from a decade of a mammography screening program.
    Breast Cancer Res Treat. 2025 Feb 12. doi: 10.1007/s10549-025-07619.
    >> Share

  22. ALBESHAN SM, Almuqbil MM, Elsharkawi MM, Nassri H, et al
    Outcomes of the Saudi breast cancer early detection program: a nine-year analysis (2012-2020).
    Breast Cancer Res Treat. 2025 Feb 14. doi: 10.1007/s10549-025-07633.
    >> Share


    Breast J

  23. TIAN L, Meng X, Si H, Qiu Y, et al
    The Relationship Between Clinicopathological Features and Prognosis of 22 Cases of Tubular Breast Carcinoma.
    Breast J. 2025;2025:5599018.
    >> Share

  24. BAKILLAH E, Brooks AD, Adekeye S
    Switching to Tumescent Dissection in Mastectomy.
    Breast J. 2025;2025:7634729.
    >> Share

  25. DHANNOON A, Balasubramanian I, Dhannoon AA, Butt A, et al
    The Risk of Haematoma and Venous Thrombosis Associated With Thromboprophylaxis Use in Breast Cancer Surgery: A Meta-Analysis and Systematic Review.
    Breast J. 2025;2025:9898596.
    >> Share


    Cancer Cell

  26. BIANCHINI G, Viale G, Dugo M
    From intrinsic to adaptive clusters in breast cancer.
    Cancer Cell. 2025;43:171-173.
    >> Share

  27. DENKERT C, Rachakonda S, Karn T, Weber K, et al
    Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping.
    Cancer Cell. 2025;43:232-247.
    >> Share


    Cancer Lett

  28. CHEN H, Lin L, Qiao Z, Pei Y, et al
    YTHDF3 drives tumor growth and metastasis by recruiting eIF4B to promote Notch2 translation in breast cancer.
    Cancer Lett. 2025;614:217534.
    >> Share


    Cancer Res

  29. ZHOU S, Zhang Y, Belmar J, Hou C, et al
    Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer.
    Cancer Res. 2025 Feb 12. doi: 10.1158/0008-5472.CAN-24-2492.
    >> Share

  30. IPPOLITOV D, Lin YH, Spence J, Glogowska A, et al
    The Brain-Penetrant Pan ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain Metastases.
    Cancer Res. 2025 Feb 11. doi: 10.1158/0008-5472.CAN-24-1793.
    >> Share


    Clin Breast Cancer

  31. DA SILVA-FILHO PPP, Buttros DAB, Buttros LAB, Esperanca G, et al
    High Risk of Metabolic Dysfunction in Nonobese Breast Cancer Survivors.
    Clin Breast Cancer. 2025 Jan 27:S1526-8209(25)00019.
    >> Share

  32. JIA Y, Gan C, Chai J, Huang R, et al
    The Effect of CALM Intervention on Negative Emotions and Sleep Quality in Patients Undergoing Endocrine Therapy for Breast Cancer.
    Clin Breast Cancer. 2025 Jan 17:S1526-8209(25)00017.
    >> Share


    Eur J Cancer

  33. METZGER FILHO O, Cardoso F, Poncet C, Desmedt C, et al
    Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial.
    Eur J Cancer. 2025;217:115222.
    >> Share


    Eur Radiol

  34. LOUIS FM, Sonke GS, Mann RM
    Image-guided adaption of systemic therapy in breast cancer patients.
    Eur Radiol. 2025 Feb 13. doi: 10.1007/s00330-025-11456.
    >> Share


    Gene

  35. SEREJ ZA, Ebrahimi A, Kazemi T, Najafi S, et al
    Retraction notice to "NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer" [GENE 801 (2021) 145844].
    Gene. 2025 Feb 8:149308. doi: 10.1016/j.gene.2025.149308.
    >> Share


    Genes Chromosomes Cancer

  36. WU S, Pan JW, Citartan M, Tang TH, et al
    Profiling Precursor microRNAs of Breast Cancer From Total RNA Sequencing Data to Gain Insights Into Their Roles and Prognostic Values.
    Genes Chromosomes Cancer. 2025;64:e70027.
    >> Share


    J Biol Chem

  37. SONG X, Liu S, Zeng Y, Cai Y, et al
    BANCR-Containing Extracellular Vesicles Enhance Breast Cancer Resistance.
    J Biol Chem. 2025 Feb 11:108304. doi: 10.1016/j.jbc.2025.108304.
    >> Share


    J Natl Cancer Inst

  38. HU P, Prorok PC, Katki HA
    Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screening.
    J Natl Cancer Inst. 2025;117:303-311.
    >> Share


    J Nucl Med

  39. SUN L, Sun Y, Zuo K, Fan L, et al
    Pilot Study of Nectin-4-Targeted PET Imaging Agent (68)Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human.
    J Nucl Med. 2025 Feb 13:jnumed.124.269024. doi: 10.2967/jnumed.124.269024.
    >> Share


    Lancet Oncol

  40. CASASSUS B
    Law to extend free medical treatment for breast cancer in France.
    Lancet Oncol. 2025 Feb 6:S1470-2045(25)00069.
    >> Share


    Mod Pathol

  41. VAZQUEZ TP, Goncalves R, Gomes da Cunha JP, Silva Rivas FW, et al
    Prognostic Implications of Magee Equation 3 and Residual Cancer Burden in patients receiving Neoadjuvant Chemotherapy for HR-Positive HER2-Negative Breast Cancer.
    Mod Pathol. 2025 Feb 7:100733. doi: 10.1016/j.modpat.2025.100733.
    >> Share


    Nature

  42. HUANG H, Hu C, Na J, Hart SN, et al
    Functional evaluation and clinical classification of BRCA2 variants.
    Nature. 2025;638:528-537.
    >> Share

  43. HOULAHAN KE, Mangiante L, Sotomayor-Vivas C, Adimoelja A, et al
    Complex rearrangements fuel ER(+) and HER2(+) breast tumours.
    Nature. 2025;638:510-518.
    >> Share


    NPJ Breast Cancer

  44. PENA-ENRIQUEZ R, Bermejo B, Pollan M, Diaz-Chacon A, et al
    Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study.
    NPJ Breast Cancer. 2025;11:12.
    >> Share

  45. LIANG H, Huang J, Li H, He W, et al
    Spatial proximity of CD8(+) T cells to tumor cells predicts neoadjuvant therapy efficacy in breast cancer.
    NPJ Breast Cancer. 2025;11:13.
    >> Share

  46. MUKHTAR RA, Gottipati S, Yau C, Lopez-Tarruella S, et al
    A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.
    NPJ Breast Cancer. 2025;11:14.
    >> Share

  47. HELAL C, Djerroudi L, Ramtohul T, Laas E, et al
    Clinico-pathological factors predicting pathological response in early triple-negative breast cancer.
    NPJ Breast Cancer. 2025;11:15.
    >> Share


    PLoS Comput Biol

  48. SHI X, Wang X, Jin L, Halakivi-Clarke L, et al
    Bayesian identification of differentially expressed isoforms using a novel joint model of RNA-seq data.
    PLoS Comput Biol. 2025;21:e1012750.
    >> Share


    PLoS One

  49. KITAGAWA T
    Hydrothermal treatment of yeast cell wall generates potent anti-proliferative agents targeting MCF7 breast cancer cells effectively even under culture conditions separated by a plastic wall.
    PLoS One. 2025;20:e0313379.
    >> Share

  50. NAFIE EHO, Pastori C, Acharya R, Kaviani R, et al
    Understanding the aliya pulsed electric field dose-response relationship: Implications for ablation size, thermal load, and immune response in an orthotopic murine breast cancer model.
    PLoS One. 2025;20:e0318440.
    >> Share

  51. OLSSON IM, Dykes C, Ryden L, Olsson-Moller U, et al
    Experiences of rehabilitation one year after breast cancer diagnosis-A focus group study from the ReScreen randomized controlled trial.
    PLoS One. 2025;20:e0315814.
    >> Share


    Radiol Artif Intell

  52. ZUCKERMAN SP, Periaswamy S, Shisler JL, Elahi A, et al
    Evaluating the Impact of Changes in Artificial Intelligence-derived Case Scores over Time on Digital Breast Tomosynthesis Screening Outcomes.
    Radiol Artif Intell. 2025;7:e230597.
    >> Share


    Radiol Imaging Cancer

  53. SINHA AP, Jurrius P, van Schelt AS, Darwish O, et al
    Tumor Biomechanics Quantified Using MR Elastography to Predict Response to Neoadjuvant Chemotherapy in Individuals with Breast Cancer.
    Radiol Imaging Cancer. 2025;7:e240138.
    >> Share


    Radiology

  54. NISSAN N, Sevilimedu V, Gluskin J, Arita Y, et al
    Hormonal Regulation of Background Parenchymal Enhancement at Contrast-enhanced Mammography.
    Radiology. 2025;314:e241158.
    >> Share


    Radiother Oncol

  55. VINCENZI MM, Cicchetti A, Castriconi R, Mangili P, et al
    Training and temporally validating an NTCP model of acute toxicity after whole breast radiotherapy, including the impact of advanced delivery techniques.
    Radiother Oncol. 2025;204:110700.
    >> Share


    Science

  56. HENIKOFF S, Zheng Y, Paranal RM, Xu Y, et al
    RNA polymerase II at histone genes predicts outcome in human cancer.
    Science. 2025;387:737-743.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016